Minister calls for end of animal testing
August 1, 2014Research and Development, Sales and Marketing Animal testing
British MP Norman Baker has called for an end to all animal testing in the UK and promised to increase …
Genomes Project gains £300m UK funding boost
August 1, 2014Medical Communications, Research and Development, Sales and Marketing Genomics england, Illumina, NHS England, david cameron, genomes
A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister …
Boehringer’s Striverdi gains FDA approval
August 1, 2014Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol
Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …
AstraZeneca’s second quarter beats estimates
July 31, 2014Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer
AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …
‘Smart pill’ creator gains new funding
July 31, 2014Medical Communications, Research and Development, Sales and Marketing digital medicine, proteus, smart pills
Proteus Digital Health has raised $172 million to help develop its new brand of smart pills that can help patients …
Cause of rare childhood cancer discovered
July 31, 2014Research and Development, Sales and Marketing Cancer, RMS, YAP, childhood cancer
Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS). Around 60 …
Tonic expands leadership team with two new hires
July 31, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Tonic Life Communications, the PR arm for Huntsworth Health, has added Tracey Carey as its new head of consumer and …
NICE won’t back Revlimid in new setting
July 31, 2014Medical Communications, Sales and Marketing Celgene, NICE, Revlimid, Thalidomide, multiple myeloma
NICE has once again said it does not think that Celgene’s rare cancer drug Revlimid should be used on the …
Dementia diagnoses on the rise
July 30, 2014Medical Communications, Research and Development, Sales and Marketing Alzheimer's, david cameron, dementia
The number of patients in England diagnosed with dementia has increased by 62% over seven years according to provisional figures …
MKTXS appoints Dr Steven Bradshaw as director
July 30, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director. Market …
AstraZeneca secures respiratory drugs from Almirall
July 30, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs
AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …
Amgen to wield axe on 2,900 jobs
July 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts
Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …
Pfizer revenue drops, but new cancer drugs shine
July 29, 2014Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra
Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …
Copycat Lipitor helps toward £1.3bn NHS savings
July 29, 2014Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba
In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …
Roche’s blood cancer drug gains EU approval
July 29, 2014Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche
The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …
Healthcare marketer Renée Mellas re-joins Area 23 as MD
July 29, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FCS Health
Healthcare and pharma marketing professional Renée Mellas has returned to Area 23, an FCB Health company, as executive vice president …
US doctor infected with Ebola as disease spreads
July 28, 2014Medical Communications, Sales and Marketing Ebola, WHO
An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …
Google hopes DNA search will yield health results
July 27, 2014Medical Communications, Research and Development, Sales and Marketing DNA, calico, google, smart lens
Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …
Europe warned over cancer research risk
July 27, 2014Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data
A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …
EMA approvals for rival blood cancer drugs
July 27, 2014Research and Development, Sales and Marketing CLL, Gilead, Janssen, chronic lymphocytic leukaemia, imbruvica, zydelig
Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
